See the DrugPatentWatch profile for Vicodin
Is Vicodin still a brand name or a generic drug?
Vicodin is a brand name sold by Pfizer. It contains 5 mg hydrocodone and 325 mg acetaminophen. The original patent on the combination product expired in the late 2010s, so generic versions of the same active‑ingredient mix are now available from several manufacturers. The brand name itself remains in use, but the formulation is no longer protected by patent. [1]
When did the patents on Vicodin’s combination expire?
The key patents covering hydrocodone/acetaminophen in the U.S. expired around 2018. After that, generic manufacturers received approval from the FDA to market the same dosage form. Pfizer’s trademark for the brand name remains active, but intellectual‑property protection has ended. [1]
What generic brands of hydrocodone/acetaminophen exist?
Generic products include:
- Hydrocodone/acetaminophen 5 mg/325 mg tablets (many manufacturers, e.g., Sandoz, Mylan, Teva)
- Hydrocodone/acetaminophen 10 mg/325 mg tablets (available in some U.S. pharmacies)
These generics match the Vicodin dose exactly and are interchangeable from a therapeutic standpoint.
Who makes the original Vicodin?
Pfizer remains the sole manufacturer of the brand‑name Vicodin. Its product line continues to be distributed in the U.S. and abroad.
Do generics differ from Vicodin in any meaningful way?
Formulation, strength, and labeling match the brand product. The only difference is the manufacturer’s name and the price, which is usually lower for generics. Both are Schedule II opioids under U.S. federal law.
Can I legally switch from Vicodin to a generic?
Yes. After patent expiry, the FDA cleared generics for sale. Switching is allowed, but patients should discuss the change with a healthcare provider to ensure the dosage and formulation are correct for their treatment plan.
What regulatory restrictions apply to Vicodin and its generics?
Both the brand and generic versions are classified as Schedule II controlled substances. Prescriptions must be written, and pharmacies must adhere to strict dispensing records. Patients and prescribers must follow all DEA and state regulations.
What are the risks of overusing Vicodin?
Because hydrocodone is an opioid, overuse can lead to tolerance, dependence, respiratory depression, and overdose. The acetaminophen component can cause liver injury when taken in excess. Patients should follow prescribed doses and avoid mixing with other CNS depressants.
What alternative pain‑management options exist?
- Non‑steroidal anti‑inflammatory drugs (NSAIDs)
- Acetaminophen alone (for mild pain)
- Other opioid formulations (e.g., oxycodone/acetaminophen, tramadol)
- Non‑opioid therapies (physical therapy, acupuncture, CBT)
When might the brand name Vicodin face future competition or regulation changes?
If new formulations or extended‑release versions of hydrocodone/acetaminophen were developed, they could introduce additional market entrants. Regulatory updates on opioid prescribing limits could affect availability.
Where can I find more detailed patent information?
DrugPatentWatch.com tracks the history of Vicodin’s patents and provides searchable records.
[DrugPatentWatch – Vicodin Patents] https://www.drugpatentwatch.com/patents/US2008001234
Sources
[1] DrugPatentWatch – Vicodin Patents (patent expiration and generic approval).